Published Erratum
doi: 10.1016/j.omtm.2024.101199.
eCollection 2024 Mar 14.
Erratum: A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products
- PMID: 38352272
- PMCID: PMC10863311
- DOI: 10.1016/j.omtm.2024.101199
Item in Clipboard
Published Erratum
Erratum: A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products
Mol Ther Methods Clin Dev.
.
Abstract
[This corrects the article DOI: 10.1016/j.omtm.2023.101150.].
© 2024 The Author(s).
Erratum for
-
A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products.Mol Ther Methods Clin Dev. 2023 Nov 7;31:101150. doi: 10.1016/j.omtm.2023.101150. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 38027059 Free PMC article.
Similar articles
-
A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products.Mol Ther Methods Clin Dev. 2023 Nov 7;31:101150. doi: 10.1016/j.omtm.2023.101150. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 38027059 Free PMC article.
-
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.J Autoimmun. 2023 Jul;138:103057. doi: 10.1016/j.jaut.2023.103057. Epub 2023 May 23. J Autoimmun. 2023. PMID: 37224732
-
Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.Mol Ther Methods Clin Dev. 2024 May 8;32(2):101262. doi: 10.1016/j.omtm.2024.101262. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38745896 Free PMC article.
-
Erratum: Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors.Mol Ther Methods Clin Dev. 2020 Nov 3;19:375. doi: 10.1016/j.omtm.2020.10.021. eCollection 2020 Dec 11. Mol Ther Methods Clin Dev. 2020. PMID: 33209962 Free PMC article.
-
Erratum: Hematopoietic stem cell gene therapy ameliorates CNS involvement in murine model of GM1-gangliosidosis.Mol Ther Methods Clin Dev. 2022 Sep 21;27:89. doi: 10.1016/j.omtm.2022.09.004. eCollection 2022 Dec 8. Mol Ther Methods Clin Dev. 2022. PMID: 36186953 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
